#relacorilant

[ follow ]
fromwww.theguardian.com
6 days ago

Repurposed drug may extend survival in aggressive ovarian cancer, trial shows

The study published in the Lancet analyzed data from 381 patients with platinum-resistant ovarian cancer, revealing a 35% reduction in the risk of death among those treated with relacorilant compared to usual care.
Cancer
Medicine
fromwww.theguardian.com
1 week ago

Is a new weight-loss drug making people fall out of love?

Retatrutide, an experimental weight-loss drug, may cause emotional flattening and affect relationships by dampening the brain's reward system.
Medicine
fromwww.scientificamerican.com
4 weeks ago

Experimental GLP-3 weight loss drug retatrutide shows promising results in clinical trial

Retatrutide, a triple-receptor GLP-3 agonist drug, achieved up to 36.6 pounds of average weight loss and improved blood sugar control in phase 3 clinical trials for type 2 diabetes.
#glp-1-receptor-agonists
Medicine
fromNature
1 month ago

Can weight-loss pills replace injectables? What the science says

Oral anti-obesity pills based on GLP-1 receptor agonists are entering the market, offering needle-free alternatives to injectable weight-loss drugs, though they produce less weight loss than injections.
fromwww.theguardian.com
2 months ago

Psychiatric drugs aren't always the answer | Letter

Yes, there has been a shocking lack of progress in developing transformative psychiatric medicine (We need new drugs for mental ill-health, 5 February), but this may be because in mental health, drugs are not always the answer (see, for example, Richard P Bentall's Doctoring the Mind). Huge progress has been made in the effectiveness of talking therapies for example, free effective treatment for post-traumatic stress disorder (PTSD) is available to all UK army veterans through the charity PTSD Resolution.
Mental health
Medicine
fromwww.theguardian.com
2 months ago

Weight-loss race: how switch from injections to pills is expanding big pharma's hopes

Oral GLP-1 weight-loss pills like Wegovy are rapidly adopted, offering easier use but raising concerns about cost, supply and side-effects.
[ Load more ]